A Novel Oncogenic Driver in a Lung Adenocarcinoma Patient Harboring an EGFR-KDD and Response to Afatinib

Introduction: Oncogenic mutations in the epidermal growth factor receptor (EGFR) occur frequently in patients with lung cancer. These mutations may serve as critical predictive biomarkers in patients with non-small cell lung cancer (NSCLC). Among them, EGFR exon 18–25 kinase domain duplication (EGFR...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Chen, Dong, Li, Xing-liang, Wu, Biao, Zheng, Xiao-bin, Wang, Wen-xian, Chen, Hua-fei, Dong, Yi-yu, Xu, Chun-wei, Fang, Mei-yu
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7325976/
https://ncbi.nlm.nih.gov/pubmed/32656077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00867
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados